Skip to content

Active ingredient

Medroxyprogesterone

48 finished FDA listings contain Medroxyprogesterone as their only active ingredient; 4 combination products also contain it.

FDA NDC Directory

Ingredient names as written by FDA
MEDROXYPROGESTERONE ACETATE
Dosage forms
Injection, Suspension, Injection, Suspension, Extended Release, Tablet
Routes
Intramuscular, Oral, Subcutaneous
Manufacturers / labelers
24
Strengths listed
10 mg/1 · 104 mg/.65ml · 150 mg/ml · 2.5 mg/1 · 5 mg/1
Brand names in FDA listings
Depo-Provera, Depo-Subq Provera, Medroxyprogesterone Acetate Injectable Suspension, Provera

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 6691

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 011839PFIZER1959-06-186
NDA 020246PFIZER1992-10-296
ANDA 040159BARR1996-08-0922
NDA 021583PFIZER2004-12-171
ANDA 077235AMPHASTAR PHARMS INC2017-11-281
ANDA 077334AMPHASTAR PHARMS INC2017-11-281
ANDA 210227XIROMED2018-10-123
ANDA 210761SUN PHARM2019-04-241
ANDA 210760SUN PHARM2019-05-011
ANDA 212824EUGIA PHARMA2022-08-221
ANDA 212844EUGIA PHARMA2022-08-311
ANDA 214309HIKMA2023-01-051
ANDA 215397AMNEAL2023-06-073

Official labeling on DailyMed

Showing the 12 most recent of 36 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.